Patients on the Transplant Waiting List Have Anti-Swine Leukocyte Antigen Class I Antibodies.
Journal
ImmunoHorizons
ISSN: 2573-7732
Titre abrégé: Immunohorizons
Pays: United States
ID NLM: 101708159
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
received:
03
08
2023
accepted:
29
08
2023
medline:
18
9
2023
pubmed:
15
9
2023
entrez:
15
9
2023
Statut:
ppublish
Résumé
Organ supply remains inadequate to meet the needs of many patients who could benefit from allotransplantation. Xenotransplantation, the use of animals as organ donors, provides an opportunity to alleviate this challenge. Pigs are widely accepted as the ideal organ donor, but humans and nonhuman primates have strong humoral immune responses to porcine tissue. Although carbohydrate xenoantigens have been studied intensively, the primate Ab response also targets class I and class II swine leukocyte Ags (SLAs). Human Abs that recognize HLAs can cross-react with SLA molecules because epitopes can be shared across species. However, ∼15% of people may also exhibit Abs toward class II SLAs despite lacking Abs that also recognize class II HLAs. Here, we extend these studies to better understand human Ab responses toward class I SLAs. When tested against a panel of 18 unique class I SLA proteins, 14 of 52 sera samples collected from patients in need of an organ transplant contained Abs that bound class I SLAs. Class I SLA-reactive sera may contain IgM only, IgG, only, or IgM and IgG capable of recognizing the pig proteins. The presence of class I HLA-reactive Abs was not essential to generating anti-class I SLA Ig. Last, anti-class I SLA reactivity varied by serum; some recognized a single SLA allele, whereas others recognized multiple class I SLA proteins.
Identifiants
pubmed: 37712913
pii: 265908
doi: 10.4049/immunohorizons.2300056
pmc: PMC10587499
doi:
Substances chimiques
Immunoglobulin G
0
Immunoglobulin M
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
619-625Subventions
Organisme : NIAID NIH HHS
ID : U19 AI142737
Pays : United States
Informations de copyright
Copyright © 2023 The Authors.
Références
J Immunol. 2014 Dec 1;193(11):5751-7
pubmed: 25339675
Hum Pathol. 1971 Jun;2(2):253-98
pubmed: 4106282
J Immunol. 2018 Apr 15;200(8):2957-2964
pubmed: 29540579
Immunogenetics. 2019 Jul;71(7):479-487
pubmed: 31270568
Nucleic Acids Res. 2017 Jan 4;45(D1):D860-D864
pubmed: 27899604
Annu Rev Anim Biosci. 2020 Feb 15;8:171-198
pubmed: 31846353
N Engl J Med. 1969 Apr 3;280(14):735-9
pubmed: 4886455
Transplantation. 2018 Feb;102(2):249-254
pubmed: 28846555
Transplantation. 2008 Sep 15;86(5):681-5
pubmed: 18791449
Ann Surg. 2021 Sep 1;274(3):473-480
pubmed: 34238812
Xenotransplantation. 2020 Jan;27(1):e12560
pubmed: 31591751
Am J Transplant. 2019 Aug;19(8):2174-2185
pubmed: 30821922
Ann Surg. 2018 Oct;268(4):564-573
pubmed: 30048323
Am J Transplant. 2018 Dec;18(12):2849-2856
pubmed: 30133953
Transplantation. 2017 Apr;101(4):e86-e92
pubmed: 28114170
Lancet. 1975 Feb 8;1(7902):304-6
pubmed: 46447
Postgrad Med J. 1971 Feb;47(544):89-100
pubmed: 4929402
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Tissue Antigens. 2005 Feb;65(2):136-49
pubmed: 15713212
Kidney360. 2023 Feb 1;4(2):278-284
pubmed: 36821619
Clin Transplant. 2021 Mar;35(3):e14214
pubmed: 33389755
Transplantation. 2016 Mar;100(3):533-7
pubmed: 26906938
Transplantation. 2019 Aug;103(8):1620-1629
pubmed: 30951017